Prolactin in headache and migraine : A systematic review of clinical studies
OBJECTIVE: To systemically review clinical studies investigating the role of prolactin and its receptors in headache and migraine.
BACKGROUND: Migraine prevalence is more common in women compared to men. As prolactin is a crucial regulator of the hypothalamus-pituitary-gonadal axis, prolactin and its receptors might contribute to signaling mechanisms underlying migraine.
METHODS: In this systematic review, we searched PubMed and EMBASE with the terms: prolactin, hyperprolactinemia, macroprolactinemia, hypoprolactinemia, migraine, headache, head pain and trigeminal pain pathway for clinical studies investigating prolactin signaling in headache and migraine. Two reviewers independently screened 841 articles for population, intervention, comparison, outcome, and study design. Studies were restricted to the English language and were excluded if they had a nonexperimental methodology.
RESULTS: Nineteen clinical studies met the inclusion criteria and were included in the qualitative and quantitative analysis. The main findings were that serum prolactin levels were found to be higher in individuals with migraine compared to healthy controls, and prolactinomas (prolactin-secreting pituitary adenomas) were correlated with higher incidence of headache in otherwise healthy individuals and migraine attacks in individuals with migraine.
CONCLUSION: Considerable evidence suggests a key role of prolactin and its receptors in migraine pathophysiology. Further randomized and placebo-controlled clinical studies targeting prolactin signaling are needed to further clarify influences of prolactin in migraine attack initiation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
---|---|
Enthalten in: |
Cephalalgia : an international journal of headache - 43(2023), 2 vom: 14. Feb., Seite 3331024221136286 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Al-Karagholi, Mohammad Al-Mahdi [VerfasserIn] |
---|
Links: |
---|
Themen: |
9002-62-4 |
---|
Anmerkungen: |
Date Completed 01.02.2023 Date Revised 08.02.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1177/03331024221136286 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352284137 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM352284137 | ||
003 | DE-627 | ||
005 | 20231226053349.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/03331024221136286 |2 doi | |
028 | 5 | 2 | |a pubmed24n1174.xml |
035 | |a (DE-627)NLM352284137 | ||
035 | |a (NLM)36718026 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Al-Karagholi, Mohammad Al-Mahdi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prolactin in headache and migraine |b A systematic review of clinical studies |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.02.2023 | ||
500 | |a Date Revised 08.02.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: To systemically review clinical studies investigating the role of prolactin and its receptors in headache and migraine | ||
520 | |a BACKGROUND: Migraine prevalence is more common in women compared to men. As prolactin is a crucial regulator of the hypothalamus-pituitary-gonadal axis, prolactin and its receptors might contribute to signaling mechanisms underlying migraine | ||
520 | |a METHODS: In this systematic review, we searched PubMed and EMBASE with the terms: prolactin, hyperprolactinemia, macroprolactinemia, hypoprolactinemia, migraine, headache, head pain and trigeminal pain pathway for clinical studies investigating prolactin signaling in headache and migraine. Two reviewers independently screened 841 articles for population, intervention, comparison, outcome, and study design. Studies were restricted to the English language and were excluded if they had a nonexperimental methodology | ||
520 | |a RESULTS: Nineteen clinical studies met the inclusion criteria and were included in the qualitative and quantitative analysis. The main findings were that serum prolactin levels were found to be higher in individuals with migraine compared to healthy controls, and prolactinomas (prolactin-secreting pituitary adenomas) were correlated with higher incidence of headache in otherwise healthy individuals and migraine attacks in individuals with migraine | ||
520 | |a CONCLUSION: Considerable evidence suggests a key role of prolactin and its receptors in migraine pathophysiology. Further randomized and placebo-controlled clinical studies targeting prolactin signaling are needed to further clarify influences of prolactin in migraine attack initiation | ||
650 | 4 | |a Systematic Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Pain | |
650 | 4 | |a pituitary gland | |
650 | 4 | |a prolactinoma | |
650 | 4 | |a sex difference | |
650 | 4 | |a trigeminal pathway | |
650 | 7 | |a Prolactin |2 NLM | |
650 | 7 | |a 9002-62-4 |2 NLM | |
700 | 1 | |a Kalatharan, Veberka |e verfasserin |4 aut | |
700 | 1 | |a Ghanizada, Hashmat |e verfasserin |4 aut | |
700 | 1 | |a Gram, Christian |e verfasserin |4 aut | |
700 | 1 | |a Dussor, Gregory |e verfasserin |4 aut | |
700 | 1 | |a Ashina, Messoud |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cephalalgia : an international journal of headache |d 1981 |g 43(2023), 2 vom: 14. Feb., Seite 3331024221136286 |w (DE-627)NLM012712523 |x 1468-2982 |7 nnns |
773 | 1 | 8 | |g volume:43 |g year:2023 |g number:2 |g day:14 |g month:02 |g pages:3331024221136286 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/03331024221136286 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 43 |j 2023 |e 2 |b 14 |c 02 |h 3331024221136286 |